Markets
Late Stage VC Rounds Start Year with Bang
|
While fiscal cliff fears and free-floating economic gloom dampened the final weeks of 2012, venture investors interested in up-and-coming companies have been busy in the first weeks of 2013. Companies that saw post-start-up VC investors coming back for more include Versartis, Streetline, Pontiflex, Panaya, LED Engin, Pure Storage, BuzzFeed and Aileron Therapeutics. Versartis, a Redwood City, Calif.-based growth hormone developer, closed a $25 million Series C round. The company is currently enrolling children for a study of VRS-317, a long-acting growth hormone for the treatment of pediatric growth hormone deficiency. Versartis is in clinical trials with both adult and pediatric versions of the hormone.



